About 8-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-7-hydroxy-4-oxo-N-[4-[2-(pentanoylamino)ethylamino]phenyl]chromene-2-carboxamide
8-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-7-hydroxy-4-oxo-N-[4-[2-(pentanoylamino)ethylamino]phenyl]chromene-2-carboxamide (PubChem CID 172651987) has the molecular formula C34H38ClN5O5
and a molecular weight of 632.16 g/mol. Its IUPAC name is 8-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-7-hydroxy-4-oxo-N-[4-[2-(pentanoylamino)ethylamino]phenyl]chromene-2-carboxamide.
Molecular Properties
| Compound Name | 8-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-7-hydroxy-4-oxo-N-[4-[2-(pentanoylamino)ethylamino]phenyl]chromene-2-carboxamide |
| PubChem CID | 172651987 |
| Molecular Formula | C34H38ClN5O5 |
| Molecular Weight | 632.16 g/mol |
| Exact Mass | 631.26 |
| IUPAC Name | 8-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-7-hydroxy-4-oxo-N-[4-[2-(pentanoylamino)ethylamino]phenyl]chromene-2-carboxamide |
| SMILES | CCCCC(=O)NCCNc1ccc(NC(=O)c2cc(=O)c3ccc(O)c(CN4CCN(c5ccc(Cl)cc5)CC4)c3o2)cc1 |
| InChI | InChI=1S/C34H38ClN5O5/c1-2-3-4-32(43)37-16-15-36-24-7-9-25(10-8-24)38-34(44)31-21-30(42)27-13-14-29(41)28(33(27)45-31)22-39-17-19-40(20-18-39)26-11-5-23(35)6-12-26/h5-14,21,36,41H,2-4,15-20,22H2,1H3,(H,37,43)(H,38,44) |
| InChIKey | UAYKEKGIULQZJT-UHFFFAOYSA-N |
| XLogP | 5.44 |
| TPSA | 127.15 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 632.16 |
| LogP ≤ 5 | 5.44 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'mannich_A(296)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Analyze 8-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-7-hydroxy-4-oxo-N-[4-[2-(pentanoylamino)ethylamino]phenyl]chromene-2-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 8-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-7-hydroxy-4-oxo-N-[4-[2-(pentanoylamino)ethylamino]phenyl]chromene-2-carboxamide?
The IUPAC name of 8-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-7-hydroxy-4-oxo-N-[4-[2-(pentanoylamino)ethylamino]phenyl]chromene-2-carboxamide (CID 172651987) is 8-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-7-hydroxy-4-oxo-N-[4-[2-(pentanoylamino)ethylamino]phenyl]chromene-2-carboxamide.
What is the SMILES notation for 8-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-7-hydroxy-4-oxo-N-[4-[2-(pentanoylamino)ethylamino]phenyl]chromene-2-carboxamide?
The canonical SMILES for 8-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-7-hydroxy-4-oxo-N-[4-[2-(pentanoylamino)ethylamino]phenyl]chromene-2-carboxamide is CCCCC(=O)NCCNc1ccc(NC(=O)c2cc(=O)c3ccc(O)c(CN4CCN(c5ccc(Cl)cc5)CC4)c3o2)cc1.
What is the InChIKey of 8-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-7-hydroxy-4-oxo-N-[4-[2-(pentanoylamino)ethylamino]phenyl]chromene-2-carboxamide?
The InChIKey is UAYKEKGIULQZJT-UHFFFAOYSA-N. The full InChI is InChI=1S/C34H38ClN5O5/c1-2-3-4-32(43)37-16-15-36-24-7-9-25(10-8-24)38-34(44)31-21-30(42)27-13-14-29(41)28(33(27)45-31)22-39-17-19-40(20-18-39)26-11-5-23(35)6-12-26/h5-14,21,36,41H,2-4,15-20,22H2,1H3,(H,37,43)(H,38,44).
What are the key properties of 8-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-7-hydroxy-4-oxo-N-[4-[2-(pentanoylamino)ethylamino]phenyl]chromene-2-carboxamide?
8-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-7-hydroxy-4-oxo-N-[4-[2-(pentanoylamino)ethylamino]phenyl]chromene-2-carboxamide has a molecular weight of 632.16 g/mol, XLogP of 5.44, 12 rotatable bonds, 4 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 8-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-7-hydroxy-4-oxo-N-[4-[2-(pentanoylamino)ethylamino]phenyl]chromene-2-carboxamide is sourced from PubChem (CID 172651987), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).